Published: 2021-02-23

COVID-19 in a bone marrow transplant patient

Ayman A. Alharbi


Coronavirus disease 2019 (COVID-19) has become a new pandemic with over 190000 cases and 7800 death reported world-wide as of 18 March 2020. Due to its high infectivity and pathogenicity, most people are vulnerable to this virus, especially those with comorbidities. According to a previous study, patients with pre-existing conditions are more likely to require mechanical ventilation, which may lead to a higher risk of death. Post-transplant patients are usually under immunosuppressive therapy; this immune deficiency status may result in opportunistic infections. For now the experience in the management of COVID-19 in the post-transplant population is limited. Here we report COVID-19 case who just underwent transplantation and did not show any disease activity, despite of his suppressed immune status.


Coronavirus, Mechanical ventilation, COVID-19

Full Text:



Kanellopoulos A, Ahmed MZ, Kishore B, Lovell R, Horgan C, Paneesha S, et al. COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience. British J Haematol. 2020;190(2):e67-70.

Zamperlini-Netto G, Fernandes JF, Garcia JL, Ribeiro AA, Camargo LF, de Moraes Terra C, et al. COVID-19 after hematopoietic stem cell transplantation: report of two children. Bone Marrow Transplantation. 2020:1-3.